Business Description
Chosa Oncology AB
ISIN : SE0007784319
Compare
Compare
Traded in other countries / regions
CHOSA.SwedenW5L.Germany IPO Date
2023-08-25Description
Chosa Oncology AB is a biotechnology company engaged in the research and development in immunotherapy on therapeutic cancer vaccines.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.88 | |||||
| Piotroski F-Score | 4/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 47.4 | |||||
| 3-Year EPS without NRI Growth Rate | 44 | |||||
| 3-Year Book Growth Rate | -62.2 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 52.78 | |||||
| 9-Day RSI | 51 | |||||
| 14-Day RSI | 48.64 | |||||
| 6-1 Month Momentum % | -28.8 | |||||
| 12-1 Month Momentum % | 37.03 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.07 | |||||
| Quick Ratio | 4.07 | |||||
| Cash Ratio | 3.9 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -50.5 | |||||
| Shareholder Yield % | -9.84 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -44.69 | |||||
| ROA % | -39.52 | |||||
| ROIC % | -60.48 | |||||
| ROC (Joel Greenblatt) % | -156.3 | |||||
| ROCE % | -42.41 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Price-to-Owner-Earnings | 25.81 | |||||
| PB Ratio | 2.9 | |||||
| Price-to-Tangible-Book | 5.06 | |||||
| Price-to-Free-Cash-Flow | 3.09 | |||||
| Price-to-Operating-Cash-Flow | 3.09 | |||||
| EV-to-EBIT | -6.23 | |||||
| EV-to-EBITDA | -6.23 | |||||
| EV-to-FCF | 2.86 | |||||
| Price-to-Net-Current-Asset-Value | 5.06 | |||||
| Price-to-Net-Cash | 5.06 | |||||
| Earnings Yield (Greenblatt) % | -16.05 | |||||
| FCF Yield % | 29.52 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Chosa Oncology AB Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | |||
| EPS (TTM) (€) | -0.036 | ||
| Beta | 0 | ||
| Volatility % | 129.16 | ||
| 14-Day RSI | 48.64 | ||
| 14-Day ATR (€) | 0.006145 | ||
| 20-Day SMA (€) | 0.04704 | ||
| 12-1 Month Momentum % | 37.03 | ||
| 52-Week Range (€) | 0.018 - 0.096 | ||
| Shares Outstanding (Mil) | 70.94 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Chosa Oncology AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Chosa Oncology AB Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Chosa Oncology AB Frequently Asked Questions
What is Chosa Oncology AB(FRA:W5L)'s stock price today?
The current price of FRA:W5L is €0.05. The 52 week high of FRA:W5L is €0.10 and 52 week low is €0.02.
When is next earnings date of Chosa Oncology AB(FRA:W5L)?
The next earnings date of Chosa Oncology AB(FRA:W5L) is 2025-02-28.
Does Chosa Oncology AB(FRA:W5L) pay dividends? If so, how much?
Chosa Oncology AB(FRA:W5L) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers